Abstract
Fluctuating blood pressure during high-intensity interval exercise (HIIT) may challenge dynamic cerebral autoregulation (dCA), specifically post-stroke after an injury to the cerebrovasculature. We hypothesized dCA would be attenuated at rest and during a sit-to-stand, immediately following and 30 min after HIIT in individuals post-stroke compared to age- and sex-matched controls (CON). HIIT switched every minute between 70% and 10% estimated maximal watts for 10 min. Mean arterial pressure (MAP) and middle cerebral artery blood velocity (MCAv) were recorded. Resting dCA measured spontaneous fluctuations in MAP and MCAv via transfer function analysis. For sit-to-stand, time delay before an increase in cerebrovascular conductance index (CVCi = MCAv/MAP), rate of regulation, and %change in MCAv and MAP were measured. Twenty-two individuals post-stroke (age 60±12 yrs, 31±16 months) and twenty-four CON (age 60±13 yrs) completed the study. VLF gain (p=0.02, η2=0.18) and normalized gain (p=0.01, η2=0.43) had a group-by-time interaction, with CON improving immediately and 30 min after HIIT. Individuals post-stroke had impaired VLF phase (p=0.03, η2=0.22) immediately following HIIT compared to CON. We found no differences in the sit-to-stand. Our study showed lower resting dCA up to 30 min after HIIT in individuals post-stroke compared to CON while the sit-to-stand response was maintained.
Competing Interest Statement
The authors have declared no competing interest.
Clinical Trial
NCT04673994
Funding Statement
AW was supported by the National Heart, Lung and Blood Institute (T32HL134643), Cardiovascular Center A.O. Smith Fellowship Scholars Program, Eunice Kennedy Shriver National Institute of Child Health and Human Development (T32HD057850), American Heart Association (898190), and Kansas Partners in Progress Inc. SEA was supported by National Center for Advancing Translational Sciences (TL1TR002368). SB and EV were supported in part by the National Institute on Aging (P30 AG072973). REDCap at University of Kansas Medical Center was supported by National Center for Research Resources (ULTR000001). The REACH laboratory was supported by Georgia Holland Endowment. The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The University of Kansas Medical Center Human Subjects Committee approved all study procedures and the Declaration of Helsinki and local statutory requirements were followed. This study was registered on clinicaltrials.gov (NCT04673994) and STROBE guidelines reported.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Data Availability
All data produced in the present study are available upon request to the authors.
